AL
ALUVI.PA UV Germi SA
- Market cap
- EUR 5.52M
- P/E
- -
- P/B
- 0.72x
- ROE
- 10.3%
- Dividend yield
- -
- Fundamental score
- 1.8/5
Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jun 2026.
Is ALUVI.PA undervalued?
Graham numberThe Graham number of UV Germi SA cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
UV Germi SA fundamental analysis
6 of 11 checks passedROE 1/2
ROE in an average range (1.58%) suggests satisfactory profitability and decent utilization of shareholders' equity.
ROA 1/2
The stock's ROA (1.13%) indicates that it's doing well in making money from the things it owns. This makes it a good option to invest and make consistent profits.
PBV 1/2
The stock's PBV ratio (1.32x) indicates a justifiable valuation, presenting a compelling choice for investors seeking reasonable returns.
DER 2/2
The stock has a low debt to equity ratio (9%), which means it has a small amount of debt compared to the ownership it holds
Revenue Growth 0/2
Regrettably, this company's revenue has shown no signs of growth over the past three years, suggesting limited potential for returns and making it a less appealing choice.
Net Profit Growth 0/2
Throughout the last five years, this company's net profit has remained unchanged, indicating a lack of growth and making it a less favorable investment option.
Assets Growth 1/2
Company's revenue has experienced consistent growth over the last three years, indicating a favorable financial trajectory and making it an attractive investment choice.
Graham Number 0/1
The company's Graham number suggests that its stock price is overestimated, implying that it may not be a promising investment opportunity.
Dividend Growth 0/2
The company's dividend growth has shown no improvement in the past three years, making it a less attractive investment option for those seeking increasing returns.
Dividend 0/2
No dividends from the company in the past three years raises doubts about its profitability for shareholders.
Buffet Intrinsic Value 1/1
The company's stock presents an enticing opportunity as it appears undervalued (178) by Warren Buffett's formula, indicating that its intrinsic value exceeds the market price.
Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score
UV Germi SA stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About UV Germi SA
UV Germi SA designs, manufactures, and sells ultraviolet devices for the treatment of pollution control, disinfection and decontamination of water, air and surfaces in France. The company offers its products in the areas of air range, surface range, drinking water range, seawater, dechloramination, drinking water private use, wastewater and industrial process water, private pool, legionella, germiserre, and industrial clean water range. The company was founded in 2009 and is…
Full company profileUV Germi SA financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 1 quarter up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
UV Germi SA annual financial statements
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 4.42M | 4.76M | 5.34M | 6.42M | 6.66M | 6.32M | 7.16M | 8.04M | 8.51M | 6.81M | 16.6M |
| Gross Profit | 3.12M | 3.33M | 1.47M | 2.26M | 215K | -157K | 194K | 6.08M | 756K | 3.11M | 934K |
| Operating Income | -333K | -256K | -449K | -94.6K | 109K | -180K | 16.9K | 288K | 543K | -87.4K | 825K |
| EBITDA | -216K | -112K | -256K | 141K | 476K | -718K | 330K | 629K | 930K | 435K | 1.62M |
| Net Income | -240K | -186K | -361K | 95.6K | 410K | -870K | 66.0K | 290K | 710K | 101K | 755K |
| EPS | -0.10 | -0.07 | -0.14 | 0.04 | 0.16 | -0.34 | 0.02 | 0.09 | 0.22 | 0.04 | 0.32 |
| Balance Sheet | |||||||||||
| Total Assets | 3.15M | 8.14M | 8.08M | 8.38M | 9.52M | 7.78M | 10.9M | 10.4M | 11.1M | 11.3M | 8.79M |
| Total Liabilities | 1.44M | 1.64M | 1.95M | 2.15M | 2.88M | 1.87M | 2.02M | 1.29M | 1.18M | 1.39M | 1.32M |
| Shareholders' Equity | 1.71M | 6.50M | 6.13M | 6.23M | 6.64M | 5.77M | 8.67M | 9.11M | 9.67M | 9.94M | 7.32M |
| Cash & Short-term Investments | 623K | 5.17M | 4.37M | 3.42M | 3.28M | 1.08M | 4.41M | 3.34M | 4.76M | 4.83M | 2.47M |
| Total Debt | 812K | 749K | 899K | 1.05M | 1.42M | 557K | 825K | 172K | 92.0K | 236K | 230K |
| Cash Flow | |||||||||||
| Operating Cash Flow | 97.0K | 288K | 193K | 210K | 539K | 626K | 627K | - | - | - | - |
| Capital Expenditure | 224K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - |
| Free Cash Flow | -127K | 288K | 193K | 210K | 539K | 626K | 627K | - | - | - | - |
| Ratios | |||||||||||
| ROE | -14.1% | -2.9% | -5.9% | 1.5% | 6.2% | -15.1% | 0.8% | 3.2% | 7.3% | 1.0% | 10.3% |
| ROA | -7.6% | -2.3% | -4.5% | 1.1% | 4.3% | -11.2% | 0.6% | 2.8% | 6.4% | 0.9% | 8.6% |
| Net Profit Margin | -5.4% | -3.9% | -6.8% | 1.5% | 6.2% | -13.8% | 0.9% | 3.6% | 8.3% | 1.5% | 4.5% |
| Debt to Equity | 0.48x | 0.12x | 0.15x | 0.17x | 0.21x | 0.10x | 0.10x | 0.02x | 0.01x | 0.02x | 0.03x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
UV Germi SA dividends
UV Germi SA has not paid dividends in the last 10 fiscal years.
Who owns UV Germi SA
- Insiders 39.76%
- Institutions 0.00%
- Public & others 60.24%
- Shares outstanding 2.38M
- Free float 2.32M
UV Germi SA company profile
- Company name
- UV Germi SA
- Ticker
- ALUVI.PA
- ISIN
- FR0011898584
- Exchange
- Euronext Paris
- Sector
- Industrials
- Industry
- Machinery
- Employees
- 50
- Fiscal year end
- December
- Address
- ZAC de la Nau, Saint-Viance, France, 19240
- Phone
- 33 5 55 88 18 88
- Website
- uvgermi.fr
About UV Germi SA
UV Germi SA designs, manufactures, and sells ultraviolet devices for the treatment of pollution control, disinfection and decontamination of water, air and surfaces in France. The company offers its products in the areas of air range, surface range, drinking water range, seawater, dechloramination, drinking water private use, wastewater and industrial process water, private pool, legionella, germiserre, and industrial clean water range. The company was founded in 2009 and is headquartered in Saint-Viance, France.
UV Germi SA management
2- Mr. Willy FortunatoCEO & Chairman
- Ms. Sandrine BordasDeputy CEO & Director